A systematic review of the food and drug administration’s ‘exception from informed consent’ pathway

Health Affairs

Volumn 37, Issue 10, 2018, Pages 1605-1614

  Feldman, William B ^a   Hey, Spencer Phillips ^b   Kesselheim, Aaron S ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; AFRICAN AMERICAN; ARTICLE; BRAIN ISCHEMIA; CLINICAL EVALUATION; CLINICAL RESEARCH; CONSULTATION; DEMOGRAPHY; EPILEPTIC STATE; EXCEPTION FROM INFORMED CONSENT; FOOD AND DRUG ADMINISTRATION; HEALTH CARE DISPARITY; HEALTH CARE QUALITY; HEART ARREST; HEART INFARCTION; HUMAN; INFORMED CONSENT; MEDICAL ETHICS; MEDLINE; MORBIDITY; MORTALITY; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; RESPIRATORY FAILURE; SUPERIORITY TRIAL; SYSTEMATIC REVIEW; TRAUMATIC BRAIN INJURY; TRAUMATIC SHOCK; VULNERABLE POPULATION; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARDS; STATISTICS AND NUMERICAL DATA; TRENDS; UNITED STATES;

AFRICAN AMERICANS; HUMANS; INFORMED CONSENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 85054086697     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2018.0501     Document Type: Article

References (41)

1. Food and Drug Administration. Guidance for institutional review boards, clinical investigators, and sponsors: exception from informed consent requirements for emergency research [Internet]. Silver Spring (MD): FDA; 2011 Mar [last updated 2013 Apr; cited 2018 Aug 9]. Available from: https://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM249673.pdf
2. Largent EA, Wendler D, Emanuel E, Miller FG. Is emergency research without initial consent justified? The consent substitute model. Arch Intern Med. 2010;170(8):668–74.
3. Rebers S, Aaronson NK, van Leeuwen FE, Schmidt MK. Exceptions to the rule of informed consent for research with an intervention. BMC Med Ethics. 2016; 17(1):9.
4. Walden G, Murphy T. Letter to Francis Collins [Internet]. Washington (DC): House of Representatives Committee on Energy and Commerce; 2017 Jun 27 [cited 2018 Aug 9]. Available from: https://archives-energycommerce.house.gov/sites/republicans.energy commerce.house.gov/files/documents/20170627NIH.pdf
5. Biros MH, Lewis RJ, Olson CM, Runge JW, Cummins RO, Fost N. Informed consent in emergency research. Consensus statement from the Coalition Conference of Acute Resuscitation and Critical Care Researchers. JAMA. 1995;273(16): 1283–7.
6. Brienza AM, Sylvester R, Ryan CM, Repine M, DiFiore S, Barone J, et al. Success rates for notification of enrollment in exception from informed consent clinical trials. Acad Emerg Med. 2016;23(7):772–5.
7. Van Belle G, Mentzelopoulos SD, Aufderheide T, May S, Nichol G. International variation in policies and practices related to informed consent in acute cardiovascular research: results from a 44 country survey. Resuscitation. 2015;91: 76–83.
8. US Senate Finance Committee [In-ternet]. Washington (DC): US Senate. News release, Grassley: FDA needs to consider concerns of Hu-Hu-man Research Protection Agency in blood substitute study; 2006 Mar 13 [cited 2018 Aug 9]. Available from: https://www.finance.senate.gov/ chairmans-news/grassley-fda-needs-to-consider-concerns-of-human-research-protection-agency-in-blood-substitute-study man
9. Murphy K. Killing a patient to save his life. New York Times. 2014 Jun 9.
10. Twilley N. Can hypothermia save gunshot victims? New Yorker [serial on the Internet]. 2016 Nov 28 [cited 2018 Aug 9]. Available from: https://www.newyorker.com/magazine/2016/11/28/can-hypothermia-save-gunshot-victims
11. Raymond TT, Carroll TG, Sales G, Morris MC. Effectiveness of the informed consent process for a pediatric resuscitation trial. Pediatrics. 2010;125(4):e866–75.
12. Mosesso VN Jr, Brown LH, Greene HL, Schmidt TA, Aufderheide TP, Sayre MR, et al. Conducting research using the emergency exception from informed consent: the Public Access Defibrillation (PAD) Trial experience. Resuscitation. 2004;61(1): 29–36.
13. Salzman JG, Frascone RJ, Godding BK, Provo TA, Gertner E. Implementing emergency research requiring exception from informed consent, community consultation, and public disclosure. Ann Emerg Med. 2007;50(4):448–55.
14. Scicluna VM, Ali MK, Pentz RD, Wright DW, Dickert NW. Does experience matter? Implications for community consultation for research in emergency settings. AJOB Empir Bioeth. 2017;8(2):75–81.
15. Holsti M, Zemek R, Baren J, Stanley RM, Mahajan P, Vance C, et al. Variation of community consultation and public disclosure for a pediatric multi-centered “exception from informed consent” trial. Clin Trials. 2015;12(1):67–76.
16. Silbergleit R, Biros MH, Harney D, Dickert N, Baren J. Implementation of the exception from informed consent regulations in a large multicenter emergency clinical trials network: the RAMPART experience. Acad Emerg Med. 2012;19(4): 448–54.
17. Sims CA, Isserman JA, Holena D, Sundaram LM, Tolstoy N, Greer S, et al. Exception from informed consent for emergency research: consulting the trauma community. J Trauma Acute Care Surg. 2013; 74(1):157–65, discussion 165–6.
18. Haggins AN, Harney D, Scott S, Silbergleit R. A systematic review of Federal Drug Administration docket for community consultation and public disclosure in exception from informed consent trials. Clin Trials. 2018;15(1):29–35.
19. Klein L, Moore J, Biros M. A 20-year review: the use of exception from informed consent and waiver of informed consent in emergency research. Acad Emerg Med. 2018 Apr 21. [Epub ahead of print].
20. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. PLoS Med. 2009;6(7): e1000097.
21. To access the appendix, click on the Details tab of the article online.
22. Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015; 313(5):471–82.
23. Selker HP, Beshansky JR, Sheehan PR, Massaro JM, Griffith JL, D’Agostino RB, et al. Out-of-hospital administration of intravenous glu-cose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial. JAMA. 2012; 307(18):1925–33.
24. Nichol G, Leroux B, Wang H, Callaway CW, Sopko G, Weisfeldt M, et al. Trial of continuous or interrupted chest compressions during CPR. N Engl J Med. 2015;373(23): 2203–14.
25. Clifton GL, Valadka A, Zygun D, Coffey CS, Drever P, Fourwinds S, et al. Very early hypothermia induction in patients with severe brain injury (the National Acute Brain Injury Study: Hypothermia II): a randomised trial. Lancet Neurol. 2011;10(2):131–9.
26. Kim F, Nichol G, Maynard C, Hallstrom A, Kudenchuk PJ, Rea T, et al. Effect of prehospital induction of mild hypothermia on survival and neurological status among adults with cardiac arrest: a randomized clinical trial. JAMA. 2014;311(1): 45–52.
27. Moore EE, Moore FA, Fabian TC, Bernard AC, Fulda GJ, Hoyt DB, et al. Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial. J Am Coll Surg. 2009;208(1):1–13.
28. Aufderheide TP, Frascone RJ, Wayne MA, Mahoney BD, Swor RA, Domeier RM, et al. Standard cardiopulmonary resuscitation versus active compression-decompression cardiopulmonary resuscitation with augmentation of negative intratho-racic pressure for out-of-hospital cardiac arrest: a randomised trial. Lancet. 2011;377(9762):301–11.
29. Robertson CS, Hannay HJ, Yamal J-M, Gopinath S, Goodman JC, Tilley BC, et al. Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial. JAMA. 2014;312(1):36–47.
30. Hallstrom AP, Ornato JP, Weisfeldt M, Travers A, Christenson J, McBurnie MA, et al. Public-access defibrillation and survival after out-of-hospital cardiac arrest. N Engl J Med. 2004;351(7):637–46.
31. Bulger EM, May S, Brasel KJ, Schreiber M, Kerby JD, Tisherman SA, et al. Out-of-hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA. 2010; 304(13):1455–64.
32. Bulger EM, May S, Kerby JD, Emerson S, Stiell IG, Schreiber MA, et al. Out-of-hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Ann Surg. 2011; 253(3):431–41.
33. Bulger EM, Jurkovich GJ, Nathens AB, Copass MK, Hanson S, Cooper C, et al. Hypertonic resuscitation of hypovolemic shock after blunt trauma: a randomized controlled trial. Arch Surg. 2008;143(2):139–48, discussion 149.
34. Stiell IG, Nichol G, Leroux BG, Rea TD, Ornato JP, Powell J, et al. Early versus later rhythm analysis in patients with out-of-hospital cardiac arrest. N Engl J Med. 2011;365(9): 787–97.
35. Food and Drug Administration. Clinical trials shed light on minority health [Internet]. Silver Spring (MD): FDA; 2013 Apr 26 [cited 2018 Aug 10]. Available from: https://www.fda.gov/ForConsumers/ ConsumerUpdates/ucm349063.htm
36. Washington HA. Medical apartheid: the dark history of medical experimentation on black Americans from colonial times to the present. New York (NY): Doubleday; 2006.
37. Reinier K, Nichols GA, Huertas-Vazquez A, Uy-Evanado A, Teodorescu C, Stecker EC, et al. Distinctive clinical profile of blacks versus whites presenting with sudden cardiac arrest. Circulation. 2015; 132(5):380–7.
38. Galea S, Blaney S, Nandi A, Silverman R, Vlahov D, Foltin G, et al. Explaining racial disparities in incidence of and survival from out-of-hospital cardiac arrest. Am J Epidemiol. 2007;166(5):534–43.
39. Sugarman J, Sitlani C, Andrusiek D, Aufderheide T, Bulger EM, Davis DP, et al. Is the enrollment of racial and ethnic minorities in research in the emergency setting equitable? Resuscitation. 2009;80(6):644–9.
40. Fehr AE, Pentz RD, Dickert NW. Learning from experience: a systematic review of community consultation acceptance data. Ann Emerg Med. 2015;65(2):162–71.e3.
41. Kerkhoff LA, Butler J, Kelkar AA, Shore S, Speight CD, Wall LK, et al. Trends in consent for clinical trials in cardiovascular disease. J Am Heart Assoc. 2016;5(6):e003582.